With respect to breast cancer, endoplasmic reticulum (ER) stress has been implicated as a therapeutic vulnerability in HER2+ breast cancer [23,24], and more recently in HER2+ breast cancer metastasis [25]. The gene discussed is ERBB2; the disease is breast carcinoma.